• English
    X

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    Maryland Department of Health
    Regulations

    ​PROPOSAL

    Maryland Register

    Issue Date:  December 21, 2018

    Volume 45 • Issue 26 • Page 1268-1269

    Title 10 
    MARYLAND DEPARTMENT OF HEALTH

    Subtitle 62 NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION

    Notice of Proposed Action

    [18-325-P]

    The Secretary of Health proposes to:

    (1) Amend Regulation .01 under COMAR 10.62.01 Definitions;

    (2) Adopt New Regulation .05 under COMAR 10.62.02 General Regulations;

    (3) Amend Regulation .05 under COMAR 10.62.08 Medical Cannabis Grower License;

    (4) Amend Regulation .04 under COMAR 10.62.19 Medical Cannabis Processor License; and

    (5) Amend Regulation .05 under COMAR 10.62.25 Medical Cannabis Dispensary License.

    Statement of Purpose

    The purpose of this action is to expand the evaluation criteria for medical cannabis licensing applications to address the needs of minority and women applicants. The proposed regulation aims to reduce barriers to entry and encourage participation in the medical cannabis industry by minorities and women.

    The regulatory changes are being made pursuant to Health-General Article, §13-3305.2, Annotated Code of Maryland, which requires the Commission to submit regulations to address the needs of minority and women business owners and entrepreneurs interested in becoming licensed in the medical cannabis industry.

     

    Comparison to Federal Standards

    There is no corresponding federal standard to this proposed action.

    Estimate of Economic Impact

    The proposed action has no economic impact.

    Economic Impact on Small Businesses

    The proposed action has minimal or no economic impact on small businesses.

    Impact on Individuals with Disabilities

    The proposed action has no impact on individuals with disabilities.

    Opportunity for Public Comment

    Comments may be sent to Jake Whitaker, Acting Director, Office of Regulation and Policy Coordination, Maryland Department of Health, 201 West Preston Street, Room 512, Baltimore, MD 21201, or call 410-767-6499 (TTY 800-735-2258), or email to mdh.regs@maryland.gov, , or fax to 410-767-6483. Comments will be accepted through January 22, 2019. A public hearing has not been scheduled.

     

       Editor’s Note: The text of this document will not be printed here because it appeared as a Notice of Emergency Action in 45:25 Md. R. 1201—1204 (December 7, 2018), referenced as [18-325-E].

    ROBERT R. NEALL
    Secretary of Health

     ​